Head of South Korea's senior public official crime investigation department: If the conditions are met, it will seek to arrest Yin Xiyue. The head of South Korea's senior public official crime investigation department said that if the conditions are met, the team will seek to arrest President Yin Xiyue or seek to issue an arrest warrant for him. On Wednesday, when answering questions raised by opposition lawmakers at the National Assembly meeting, Oh Dong-woon indicated that he had the intention to arrest Yin Xiyue.Academician Qiao Jie, Executive Vice President of Peking University, and his party visited Sunflower Pharmaceutical Group. On December 9th, Academician Qiao Jie, Executive Vice President of Peking University, and his party visited the headquarters of Sunflower Pharmaceutical Group for investigation and exchange. At the symposium, Tan Lei, general manager of the strategic management department of Sunflower Pharmaceutical Group, gave a detailed report on the promotion plan of the project "Peking University Medical-Sunflower Pharmaceutical Group Joint Laboratory of Bacterial Enzyme and Innovative Drugs". Sunflower Pharmaceutical Group will join hands with Peking University Medical Center, and the teams of the two sides will cooperate in depth to jointly develop new drugs based on the active substances of traditional Chinese medicine and the discovered important disease targets, promote the transformation of scientific research achievements, deepen the advantageous fields of biotechnology, and help improve the scientific research and innovation ability and technology development level. During the talks, the two sides also conducted in-depth exchanges and discussions on a number of contents.Yanshan Technology has set up a new subsidiary in Shanghai. According to the enterprise search APP, Shanghai Yunsong Technology Co., Ltd. was recently established with Zhang Weiming as the legal representative and a registered capital of 10 million yuan. Its business scope includes technical services, technical development, technical consultation, technical exchange, technology transfer and technology promotion. Enterprise equity penetration shows that the company is wholly owned by Yanshan Technology.
Academician Qiao Jie, Executive Vice President of Peking University, and his party visited Sunflower Pharmaceutical Group. On December 9th, Academician Qiao Jie, Executive Vice President of Peking University, and his party visited the headquarters of Sunflower Pharmaceutical Group for investigation and exchange. At the symposium, Tan Lei, general manager of the strategic management department of Sunflower Pharmaceutical Group, gave a detailed report on the promotion plan of the project "Peking University Medical-Sunflower Pharmaceutical Group Joint Laboratory of Bacterial Enzyme and Innovative Drugs". Sunflower Pharmaceutical Group will join hands with Peking University Medical Center, and the teams of the two sides will cooperate in depth to jointly develop new drugs based on the active substances of traditional Chinese medicine and the discovered important disease targets, promote the transformation of scientific research achievements, deepen the advantageous fields of biotechnology, and help improve the scientific research and innovation ability and technology development level. During the talks, the two sides also conducted in-depth exchanges and discussions on a number of contents.According to a survey conducted by the Monetary Authority of Singapore, Singapore's GDP growth rate is expected to be 3.6% in 2024 (previously 2.6%) and 3.1% in the fourth quarter of 2024 (previously 2.2%).Institution: In the first half of 2024, the scale of China's edge cloud market increased by 21% year-on-year. Recently, the latest report "China Edge Cloud Market Tracking Research, 2024H1" released by International Data Corporation (IDC) shows that in the first half of 2024, the scale of China's edge cloud market totaled 5.48 billion yuan, with a year-on-year growth rate of 21.0%. Among them, the market scale of edge public cloud services, edge exclusive cloud services and edge cloud solutions reached RMB 3.00 billion, RMB 970 million and RMB 1.50 billion respectively. Internet audio and video distribution and real-time interaction based on edge resources, edge game clothes, cloud terminals and cloud games, cloud network services, and lightweight IT architecture migration of local industry customers are the core driving forces for market growth in this period.
Palestinian health department: 60 wounded people in a hospital in northern Gaza are facing death danger. The Palestinian health department announced on the 11th local time that 60 wounded people in Indonesian hospital in northern Gaza are facing death danger due to lack of food and water, and the humanitarian situation in the hospital has become extremely critical. The department called on all parties concerned and humanitarian organizations to intervene immediately and provide necessary assistance.Palestinian health department: 60 wounded people in a hospital in northern Gaza are facing death danger. The Palestinian health department announced on the 11th local time that 60 wounded people in Indonesian hospital in northern Gaza are facing death danger due to lack of food and water, and the humanitarian situation in the hospital has become extremely critical. The department called on all parties concerned and humanitarian organizations to intervene immediately and provide necessary assistance.Academician Qiao Jie, Executive Vice President of Peking University, and his party visited Sunflower Pharmaceutical Group. On December 9th, Academician Qiao Jie, Executive Vice President of Peking University, and his party visited the headquarters of Sunflower Pharmaceutical Group for investigation and exchange. At the symposium, Tan Lei, general manager of the strategic management department of Sunflower Pharmaceutical Group, gave a detailed report on the promotion plan of the project "Peking University Medical-Sunflower Pharmaceutical Group Joint Laboratory of Bacterial Enzyme and Innovative Drugs". Sunflower Pharmaceutical Group will join hands with Peking University Medical Center, and the teams of the two sides will cooperate in depth to jointly develop new drugs based on the active substances of traditional Chinese medicine and the discovered important disease targets, promote the transformation of scientific research achievements, deepen the advantageous fields of biotechnology, and help improve the scientific research and innovation ability and technology development level. During the talks, the two sides also conducted in-depth exchanges and discussions on a number of contents.
Strategy guide 12-14
Strategy guide
12-14
Strategy guide 12-14
Strategy guide 12-14